Role of exosomes in malignant glioma: microRNAs and proteins in pathogenesis and diagnosis

AB Ghaemmaghami, M Mahjoubin-Tehran… - Cell Communication and …, 2020 - Springer
Malignant gliomas are the most common and deadly type of central nervous system tumors.
Despite some advances in treatment, the mean survival time remains only about 1.25 years …

Advances in nanomedicines for diagnosis of central nervous system disorders

X Zhang, J Zhou, Z Gu, H Zhang, Q Gong, K Luo - Biomaterials, 2021 - Elsevier
In spite of a great improvement in medical health services and an increase in lifespan, we
have witnessed a skyrocket increase in the incidence of central nervous system (CNS) …

Liquid biopsy in glioblastoma

L Ronvaux, M Riva, A Coosemans, M Herzog… - Cancers, 2022 - mdpi.com
Simple Summary Glioblastoma is the most common and malignant primary brain tumor.
Despite intensive research for new treatments, the survival of patients has not significantly …

Hypoxic cancer-secreted exosomal miR-182-5p promotes glioblastoma angiogenesis by targeting Kruppel-like factor 2 and 4

J Li, H Yuan, H Xu, H Zhao, N Xiong - Molecular Cancer Research, 2020 - AACR
Glioblastoma (GBM) is the most lethal primary brain tumor and has a complex molecular
profile. Hypoxia plays a critical role during tumor progression and in the tumor …

Liquid biopsy and primary brain tumors

RH Eibl, M Schneemann - Cancers, 2021 - mdpi.com
Simple Summary Despite a substantial increase in publications in recent years, liquid biopsy
from blood, cerebrospinal fluid (CSF), and other body fluids is usually not routinely used in …

Therapeutic and diagnostic potential of exosomes as drug delivery systems in brain cancer

DI Avgoulas, KS Tasioulis, RM Papi, AA Pantazaki - Pharmaceutics, 2023 - mdpi.com
Cancer is designated as one of the principal causes of mortality universally. Among different
types of cancer, brain cancer remains the most challenging one due to its aggressiveness …

Cell-free DNA technologies for the analysis of brain cancer

R Mair, F Mouliere - British journal of cancer, 2022 - nature.com
Survival for glioma patients has shown minimal improvement over the past 20 years. The
ability to detect and monitor gliomas relies primarily upon imaging technologies that lack …

Circulating biomarkers for glioma: a review

J Jones, H Nguyen, K Drummond, A Morokoff - Neurosurgery, 2021 - journals.lww.com
Accurate circulating biomarkers have potential clinical applications in population screening,
tumor subclassification, monitoring tumor status, and the delivery of individualized …

Exosomes as cell-derivative carriers in the diagnosis and treatment of central nervous system diseases

GG Shetgaonkar, SM Marques, CEM DCruz… - Drug Delivery and …, 2022 - Springer
Exosomes are extracellular vesicles with the diameter ranging from 50 to 100 nm and are
found in different body fluids such as blood, cerebrospinal fluid (CSF), urine and saliva. Like …

Single molecule characterization of individual extracellular vesicles from pancreatic cancer

KM Lennon, DL Wakefield, AL Maddox… - Journal of …, 2019 - Taylor & Francis
Biofluid-accessible extracellular vesicles (EVs) may represent a new means to improve the
sensitivity and specificity of detecting disease. However, current methods to isolate EVs …